Kintsugi Therapeutics
Kintsugi Therapeutics is a preclinical biopharmaceutical company focused on the development of drugs for the treatment of metabolic and neurodegenerative diseases.
Kintsugi Therapeutics has raised €1.0M across 1 funding round from 1 investor, most recently a Crowdfunding round in Nov 2021. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.
Barcelona, Spainwww.kintsugitherapeutics.com ↗
Total raised
€1.0M
€986,000
Funding rounds
1
Investors
1
distinct backers
Active since
2021-11
latest 2021-11
Funding by year
EUR raised per yearKintsugi Therapeutics — funding by year — interactive chart.
Data table
| Kintsugi Therapeutics — funding by year | |
|---|---|
| 2021 | €1.0M |
Signals
High confidenceRaise-next likelihood6
base rate 33% for Crowdfunding
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-11 | Crowdfunding | €1.0M | Capital Cell | View deal → |
Investors
1Related news
- Kintsugi cierra la ronda y levanta €986.000 en @CapitalCellNet en menos de una semanacapital-riesgo.es · 2021-11
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData